Comparison of PD-L1 Immunohistochemical Staining between EBUS-TBNA and Resected Non-Small Cell Lung Cancer Specimens

被引：0
|
作者：
Sakata, K. [1 ]
Midthun, D. [1 ]
Mullon, J. [2 ]
Kern, R. [2 ]
Nelson, D. [2 ]
Edell, E. [1 ]
Jett, J. [3 ]
Aubry, M. C. [4 ]
机构：
[1] Mayo Clin, Pulm & Crit Care Med, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Natl Jewish Hlth, Denver, CO USA
[4] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Non-small cell lung cancer; PD-L1; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-016
引用
收藏
页码：S2000 / S2001
页数：2
相关论文
共 50 条
  • [1] Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
    Puig Sanchez, Francisco Guillermo
    Roman Rodriguez, Lucas
    Barca Hernando, Maria
    Marquez Martin, Eduardo
    Romero Romero, Beatriz
    Martin Juan, Jose
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [2] Feasibility Of Pd-L1 Expression Testing In Non-Small Cell Lung Cancer From Ebus-Tbna Samples
    Lee, J. M.
    Kim, J. S.
    Heymann, J. J.
    Pagan, C.
    Crapanzano, J. P.
    Fazlollahi, L.
    Haghighi, M.
    Stoopler, M. B.
    Sonett, J. R.
    Sacher, A. G.
    Shu, C. A.
    Rizvi, N. A.
    Bulman, W. A.
    Saqi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Diagnostic Yield of EBUS-TBNA in Evaluation of PD-L1 Expression for Advanced Non-Small Cell Lung Cancer
    Mineura, K.
    Hamaji, M.
    Tanaka, S.
    Yutaka, Y.
    Nakajima, D.
    Yamada, Y.
    Ohsumi, A.
    Menju, T.
    Chen-Yoshikawa, T. F.
    Date, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S750 - S750
  • [4] Roles of EBUS-TBNA in non-small cell lung cancer
    Chung, Fu-Tsai
    Kuo, Chih-Hsi
    Chen, Hao-Cheng
    Feng, Po-Hao
    Lin, Shu-Min
    Yu, Chih-Ten
    Liu, Chien-Ying
    Wang, Chih-Wei
    Kuo, Han-Pin
    THORACIC CANCER, 2012, 3 (02) : 182 - 187
  • [5] Feasibility of EBUS-TBNA specimens for PD-L1 expression test in lung cancer.
    Tambo, Yuichi
    Sakakibara, Rie
    Motoi, Noriko
    Ohyanagi, Fumiyoshi
    Kitazono, Satoru
    Horiike, Atsushi
    Yanagitani, Noriko
    Oguri, Tomoyo
    Kawashima, Yosuke
    Takano, Natsuki
    Ishikawa, Yuichi
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] PD-L1 Testing of EBUS-TBNA Samples Acquired for the Diagnosis and Staging of Non-Small Cell Lung Cancer: Feasibility and Results
    Smith, A.
    Wang, H.
    Zerbo, A.
    Beaudoin, S.
    Ofiara, L. M.
    Benedetti, A.
    Gonzalez, A. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA
    Steinfort, Daniel P.
    Russell, Prudence A.
    Tsui, Alpha
    White, Gordon
    Wright, Gavin
    Irving, Louis B.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (03) : 699 - 705
  • [8] Are EUS-FNA and EBUS-TBNA specimens reliable for subtyping non-small cell lung cancer?
    Tournoy, K. G.
    Carprieaux, M.
    Deschepper, E.
    van Meerbeeck, J. P.
    Praet, M.
    LUNG CANCER, 2012, 76 (01) : 46 - 50
  • [9] EBUS-TBNA for the Mediastinal Staging of Non-small Cell Lung Cancer Response
    Rintoul, Robert C.
    Tournoy, Kurt G.
    Annema, Jouke T.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 776 - 777
  • [10] PD-LI Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA
    Fernandez-Bussy, Sebastian
    Pires, Yumay
    Labarca, Gonzalo
    Vial, Macarena R.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (05): : 290 - 292
12345